The increase in IL-33 in nasal aspirates from infants along with our mouse data cumulatively suggest that IL-33 and ILC2s are critical for the age-dependent development of asthma following severe RSV infection during infancy and that they may be a plausible therapeutic target. Here, IL33 is linked to asthma.